Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Deferasirox 360 mg film-coated tablets

Active Ingredient:
deferasirox
Company:  
Ranbaxy (UK) Limited a Sun Pharmaceutical Company See contact details
ATC code: 
V03AC03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Communication plan-Deferasirox

Communication plan for deferasirox tablets

{pdf_link}

Information for HCPs-Deferasirox

{healthcare_pro_orange} For Healthcare Professionals

Important Information for Healthcare Professionals to Remember About Deferasirox SUN (deferasirox) Treatment

{pdf_link}

Information for patients-Deferasirox

Important information for patients about your treatment and possible side effects - Deferasirox

{pdf_link}

Physician reference checklist - Deferasirox

Physician’s reference checklist for Deferasiroxdosing and biological monitoring

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Company image
Address
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, UK
Telephone
+44 (0) 208 848 8688
Medical Information Direct Line
+44 (0) 208 848 5052
WWW
http://www.sunpharma.com
Medical Information e-mail
[email protected]
Out of Hours contact
[email protected]
E-mail
[email protected]